”Source? Your link only has CFR (and >10%)” The link I provided has IFR, and is where I got the NYC numbers I quoted. They’re in the bar graph, expressed as ra

”Source? Your link only has CFR (and >10%)” The link I provided has IFR, and is where I got the NYC numbers I quoted. They’re in the bar graph, expressed as rates per 100k. The best reference I know of for a global, age-adjusted IFR as of early April is here (their estimate is 0.66%): https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30243-7.pdf https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099... However, more recent papers have come out, suggesting much lower values. For example, this paper estimates a a value of 0.08% for patients under 70, using antibody data in blood donors in Denmark: https://www.medrxiv.org/content/10.1101/2020.04.24.20075291v1 https://www.medrxiv.org/content/10.1101/2020.04.24.20075291v... My stated estimate is conservative. If anything we are continually reducing the number as we gather more data on prevalence. Regardless, a range of 0.5-1% is a safe bound for the highest quality estimates of IFR. The values cited by the OP (>>1.5%) are far too high, and based on severity-biased samples were gathered early in the pandemic.